Functional Consequences of the Human Cardiac Troponin I Hypertrophic Cardiomyopathy Mutation R145G in Transgenic Mice
Open Access
- 1 July 2008
- journal article
- Published by Elsevier BV
- Vol. 283 (29), 20484-20494
- https://doi.org/10.1074/jbc.m801661200
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Prolonged Ca2+ and Force Transients in Myosin RLC Transgenic Mouse Fibers Expressing Malignant and Benign FHC MutationsJournal of Molecular Biology, 2006
- Impact of beta-myosin heavy chain expression on cardiac function during stressJournal of the American College of Cardiology, 2004
- Prevalence and Spectrum of Thin Filament Mutations in an Outpatient Referral Population With Hypertrophic CardiomyopathyCirculation, 2003
- Functional Analysis of a Troponin I (R145G) Mutation Associated with Familial Hypertrophic CardiomyopathyPublished by Elsevier BV ,2002
- Two mutations in troponin I that cause hypertrophic cardiomyopathy have contrasting effects on cardiac muscle contractilityBiochemical Journal, 2002
- Functional Consequences of the Mutations in Human Cardiac Troponin I Gene Found in Familial Hypertrophic CardiomyopathyJournal of Molecular and Cellular Cardiology, 2001
- An abnormal Ca2+ response in mutant sarcomere protein–mediated familial hypertrophic cardiomyopathyJCI Insight, 2000
- Molecular Genetic Basis of Hypertrophic Cardiomyopathy:Journal of Cardiovascular Electrophysiology, 1998
- Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies.Heart, 1980
- Troponin, tripomyosin, and actin interactions in the Ca2+ion regulation of muscle contractionBiochemistry, 1974